DUBLIN, Ireland--(BUSINESS WIRE)-- Covidien (NYSE: COV) today announced CE Mark approval for its Nellcor™ Bedside SpO 2 Patient Monitoring System, PM100N. The system currently is available in the ...

The Nellcor Bedside SpO2 Patient Monitoring System provides clinicians with access to real-time patient respiratory status information including continuous SpO2, pulse rate monitoring and trending ...

<0> CovidienRhonda Luniak, 303-305-2263Vice PresidentR&MS CommunicationsorBruce Farmer, 508-452-4372Vice PresidentPublic RelationsorColeman Lannum, CFA, 508-452-4343Vice PresidentInvestor ...

Leading health care products company, Covidien plc. (COV) recently won the U.S. Food and Drug Administration (:FDA) 510(k) approval as well as the European Economic Area (EEA) CE Mark clearance for ...

Medtronic plc MDT recently announced favourable outcome of an independent prospective observational study, which was published online in the Journal of Perinatology. This study compared the efficacy ...

The U.S. Food and Drug Administration has granted Covidien 510(k) clearance to market the company’s Nellcor Bedside SpO2 Patient Monitoring System. The Nellcor Bedside SpO2 system with OxiMax ...

Nellcor pulse oximeters only FDA 510(k)-cleared oximeters compliant with ISO 80601-2-61 BOULDER, Colo.--(BUSINESS WIRE)-- Covidien, a leading global provider of healthcare products and recognized ...

Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care solutions, today announced the U.S. Food and Drug ...

Covidien (NYSE: COV) today announced CE Mark approval for its Nellcor™ Bedside SpO 2 Patient Monitoring System, PM100N. The system currently is available in the European Economic Area (EEA), Australia ...

Covidien Receives FDA 510(k) Clearance for Nellcor™ Pulse Oximetry Motion Claims Nellcor pulse oximeters only FDA 510(k)-cleared oximeters compliant with ISO 80601-2-61 BOULDER, Colo.--(BUSINESS WIRE) ...